What Spyre Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 42 | 96 |
| Total trades | 50 | 116 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 102,332 | 987,697 |
| Disposed | 183,564 | 5,288,803 |
| Net activity | −81,232 | −4,301,106 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| King-Jones Heidy | See Remarks | Oct 01 | Open-market sale · S | −2,600 | $93.46 | −$243K | 2,845 |
| King-Jones Heidy | See Remarks | Oct 01 | Open-market sale · S | −2,100 | $92.70 | −$195K | 5,445 |
| King-Jones Heidy | See Remarks | Oct 01 | Open-market sale · S | −7,228 | $91.35 | −$660K | 7,545 |
| King-Jones Heidy | See Remarks | Oct 01 | Open-market sale · S | −16,605 | $90.35 | −$1.5M | 14,773 |
| King-Jones Heidy | See Remarks | Oct 01 | Open-market sale · S | −400 | $89.24 | −$35.7K | 31,378 |
| King-Jones Heidy | See Remarks | Oct 01 | Exercise / conversion · M | +28,933 | $14.50 | +$420K | 31,778 |
| Burrows Scott L | Chief Financial Officer | Oct 01 | Open-market sale · S | −229 | $93.57 | −$21.4K | 79,762 |
| Burrows Scott L | Chief Financial Officer | Oct 01 | Open-market sale · S | −3,071 | $92.95 | −$285K | 79,991 |
| Burrows Scott L | Chief Financial Officer | Oct 01 | Open-market sale · S | −2,100 | $91.92 | −$193K | 83,062 |
| Burrows Scott L | Chief Financial Officer | Oct 01 | Open-market sale · S | −1,500 | $90.27 | −$135K | 85,162 |
| Burrows Scott L | Chief Financial Officer | Oct 01 | Open-market sale · S | −600 | $89.07 | −$53.4K | 86,662 |
| Burrows Scott L | Chief Financial Officer | Oct 01 | Exercise / conversion · M | +7,500 | $14.50 | +$109K | 87,262 |
| Turtle Cameron | Chief Executive Officer | Oct 01 | Open-market sale · S | −100 | $93.91 | −$9.39K | 537,540 |
| Turtle Cameron | Chief Executive Officer | Oct 01 | Open-market sale · S | −4,990 | $93.37 | −$466K | 537,640 |
| Turtle Cameron | Chief Executive Officer | Oct 01 | Open-market sale · S | −3,989 | $92.31 | −$368K | 542,630 |
| Turtle Cameron | Chief Executive Officer | Oct 01 | Open-market sale · S | −2,638 | $91.49 | −$241K | 546,619 |
| Turtle Cameron | Chief Executive Officer | Oct 01 | Open-market sale · S | −2,683 | $90.10 | −$242K | 549,257 |
| Turtle Cameron | Chief Executive Officer | Oct 01 | Open-market sale · S | −600 | $89.14 | −$53.5K | 551,940 |
| Burrows Scott L | Chief Financial Officer | Sep 30 | Open-market sale · S | −17,500 | $89.89 | −$1.57M | 79,762 |
| Burrows Scott L | Chief Financial Officer | Sep 30 | Exercise / conversion · M | +17,500 | $14.50 | +$254K | 97,262 |
Loading...